BIOMARIN PHARMACEUTICAL INC (BMRN) Stock Income Statement
NASDAQ:BMRN - Nasdaq - US09061G1013 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.95B | 2.85B | 2.42B | 2.10B | 1.85B | |||
| Cost Of Goods | 606.61M | 580.24M | 532.06M | 483.70M | 470.50M | |||
| Gross Profit | 2.34B | 2.27B | 1.89B | 1.61B | 1.38B | |||
| Operating Expenses | 1.63B | 1.70B | 1.70B | 1.55B | 1.46B | |||
| Research and Development | 700.93M | 747.18M | 746.77M | 649.60M | 628.80M | |||
| Selling, General, and Administrative Expenses | 896.85M | 913.20M | 892.41M | 831.00M | 760.90M | |||
| Operating Income | 712.03M | 570.04M | 185.77M | 64.60M | -83.80M | |||
| Interest Income/Expense | 62.55M | 62.22M | 41.00M | 2.10M | -3.40M | |||
| Other Income/Expense | -7.89M | -4.67M | -38.22M | -2.10M | 11.80M | |||
| Non Recurring Items | -92.39M | -85.83M | 0.00 | 85.00M | 0.00 | |||
| Income Before Taxes | 674.30M | 541.76M | 188.56M | 149.60M | -75.40M | |||
| Income Tax | 150.42M | 114.90M | 20.92M | 8.00M | -7.40M | |||
| Net Income | 523.88M | 426.86M | 167.65M | 141.60M | -64.10M | |||
| EBITDA | 803.18M | 666.47M | 290.16M | 166.60M | 24.20M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.69 | 2.17 | 0.88 | 0.75 | -0.37 | |||
| Non GAAP EPS | 2.88 | 2.21 | 0.95 | 0.29 | -0.36 | |||
| Statistics | ||||||||
| Gross Profit Margin | 79.44% | 79.67% | 78.01% | 76.93% | 74.52% | |||
| Profit Margin | 17.76% | 14.96% | 6.93% | 6.76% | -3.47% | |||
| Operating Profit Margin | 24.13% | 19.97% | 7.68% | 3.08% | -4.54% | |||
All data in USD